Singapore - English - HSA (Health Sciences Authority)

bristol-myers squibb (singapore) pte. ltd. - atazanavir sulfate 170.83 mg eqv atazanavir - capsule - 150 mg - atazanavir sulfate 170.83 mg eqv atazanavir 150 mg

Singapore - English - HSA (Health Sciences Authority)

bristol-myers squibb (singapore) pte. ltd. - atazanavir sulfate 227.77 mg eqv atazanavir - capsule - 200 mg - atazanavir sulfate 227.77 mg eqv atazanavir 200 mg

Singapore - English - HSA (Health Sciences Authority)

pfizer private limited - medroxyprogesterone acetate (milled) - tablet - 5 mg - medroxyprogesterone acetate (milled) 5 mg

Singapore - English - HSA (Health Sciences Authority)

pfizer private limited - medroxyprogesterone acetate (milled) - tablet - 10 mg - medroxyprogesterone acetate (milled) 10 mg

European Union - English - EMA (European Medicines Agency)

merck sharp dohme ltd - human papillomavirus type 6 l1 protein, human papillomavirus type 11 l1 protein, human papillomavirus type 16 l1 protein, human papillomavirus type 18 l1 protein - papillomavirus infections; uterine cervical dysplasia; condylomata acuminata; immunization - vaccines - silgard is a vaccine for use from the age of 9 years for the prevention of:premalignant genital lesions (cervical, vulvar and vaginal), premalignant anal lesions, cervical cancers and anal cancers causally related to certain oncogenic human papillomavirus (hpv) types;genital warts (condyloma acuminata) causally related to specific hpv types.see sections 4.4 and 5.1 for important information on the data that support this indication.the use of silgard should be in accordance with official recommendations.

Australia - English - Department of Health (Therapeutic Goods Administration)

grifols australia pty ltd - alpha-1-proteinase inhibitor, quantity: 1000 mg - solution - excipient ingredients: monobasic sodium phosphate; alanine; water for injections - prolastin? c liquid is an alpha-1-proteinase inhibitor indicated to increase serum alpha-1-proteinase inhibitor levels in adults with congenital deficiency of alpha-1-antitrypsin and with clinically significant emphysema (fev1 <80%).,the data for clinical efficacy of prolastin? c liquid is derived from changes in the biomarkers alpha-1 anti-protease level and ct lung density. efficacy on fev1 or patient relevant endpoints such as quality of life or pulmonary exacerbations has not been established in randomised clinical trials.,clinical trials have only included patients who were not smoking.

Israel - English - Ministry of Health

abic marketing ltd, israel - bortezomib - powder for solution for injection - bortezomib 3.5 mg - bortezomib - bortezo teva is indicated for the treatment of patients with multiple myeloma. bortezo teva is indicated for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy. bortezo teva in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation.

Israel - English - Ministry of Health

taro international ltd, israel - bortezomib - powder for solution for injection - bortezomib 3.5 mg/vial - bortezomib - bortezomib is indicated for the treatment of patients with multiple myeloma.bortezomib is indicated for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy. bortezomib in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation.

Singapore - English - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - efavirenz - tablet - 200.0 mg - efavirenz 200.0 mg

Singapore - English - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - imatinib mesylate 119.5 mg eqv imatinib base - tablet, film coated - 100 mg - imatinib mesylate 119.5 mg eqv imatinib base 100 mg